Rottenstreich Amihai
Laboratory of Blood and Vascular Biology, Rockefeller University, New York, NY 10065, USA.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA.
J Clin Med. 2024 Jul 29;13(15):4427. doi: 10.3390/jcm13154427.
Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality worldwide. In recent decades, many studies have evaluated different interventions in order to prevent the occurrence of preeclampsia. Among these, administration of low-dose aspirin from early pregnancy showed consistent evidence of its prophylactic role. In this article, we review the scientific literature on this topic, highlighting the rationale for aspirin use, who should be treated, the timing of initiation and cessation of therapy, the importance of proper dosing, and its role in the prevention of other adverse outcomes.
子痫前期是全球孕产妇和围产儿发病及死亡的主要原因之一。近几十年来,许多研究评估了不同的干预措施以预防子痫前期的发生。其中,从妊娠早期开始服用低剂量阿司匹林显示出其预防作用的一致证据。在本文中,我们回顾了关于这一主题的科学文献,强调了使用阿司匹林的理论依据、应接受治疗的人群、治疗开始和停止的时间、正确给药的重要性及其在预防其他不良结局中的作用。